Literature DB >> 17030765

Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.

Sung B Lee1, Edward M Manno, Kennith F Layton, Eelco F M Wijdicks.   

Abstract

To identify hematoma progression in patients with warfarin-associated intracerebral hemorrhage (ICH) despite international normalized ratio (INR) normalization with fresh-frozen plasma (FFP), we reviewed 45 patients with warfarin-associated ICH given FFP. The median time for door to INR normalization was 30 hours (14 to 49.5), with 4 patients' hematomas enlarging after INR normalization. FFP is associated with substantial time delay to actual administration and pulmonary edema and may not prevent progression of ICH despite INR normalization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030765     DOI: 10.1212/01.wnl.0000238104.75563.2f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  Management of Postthrombolysis Hemorrhagic and Orolingual Angioedema Complications.

Authors:  Cumara B O'Carroll; Maria I Aguilar
Journal:  Neurohospitalist       Date:  2015-07

2.  Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage.

Authors:  Michael Moussouttas
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

3.  Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage.

Authors:  Timolaos Rizos; Ekkehart Jenetzky; Christian Herweh; Andreas Unterberg; Werner Hacke; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 4.  Should anticoagulation be resumed after intracerebral hemorrhage?

Authors:  Joshua N Goldstein; Steven M Greenberg
Journal:  Cleve Clin J Med       Date:  2010-11       Impact factor: 2.321

Review 5.  Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment.

Authors:  Shadi Yaghi; Andrew Eisenberger; Joshua Z Willey
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

Review 6.  Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.

Authors:  Joshua A Stone; Joshua Z Willey; Salah Keyrouz; James Butera; Ryan A McTaggart; Shawna Cutting; Brian Silver; Bradford Thompson; Karen L Furie; Shadi Yaghi
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

Review 7.  Oral anticoagulant-associated intracerebral hemorrhage.

Authors:  Alvaro Cervera; Sergio Amaro; Angel Chamorro
Journal:  J Neurol       Date:  2011-07-05       Impact factor: 4.849

Review 8.  [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists].

Authors:  Marzia Angelo; Ingrid Stockner; Christian J Wiedermann
Journal:  Wien Med Wochenschr       Date:  2008

Review 9.  Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.

Authors:  Michael Makris; Joost J van Veen; Rhona Maclean
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

Review 10.  Warfarin reversal in anticoagulant-associated intracerebral hemorrhage.

Authors:  Joshua N Goldstein; Jonathan Rosand; Lee H Schwamm
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.